137 results on '"Alisi A"'
Search Results
2. The application of artificial intelligence in hepatology: A systematic review
3. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
4. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD
5. Artificial Intelligence and liver: Opportunities and barriers
6. B-Klotho deficiency in hepatic stellate cells (HSCs) prompts inflammation, oxidative stress and a pro-fibrotic phenotype
7. Intestinal activation of the lxr-α receptor protects the liver from NASH-related damage
8. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)
9. Reduced lysosomal acid lipase activity – A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients
10. Corrigendum to “Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)” [Dig Liver Dis 54 (2022) 170–182]
11. Accurate classification of liver nuclei based on AI models for diagnostic support of hepatocellular carcinoma
12. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
13. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
14. Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' [Dig Liver Dis 54 (2022) 170–182]
15. Intestinal activation of the lxr-α receptor protects the liver from NASH-related damage
16. B-Klotho deficiency in hepatic stellate cells (HSCs) prompts inflammation, oxidative stress and a pro-fibrotic phenotype
17. Hydroxytyrosol and vitamin E combination therapy exerts beneficial effects on NAFLD-related fibrosis
18. Oleuropein prevents liver damage in NAFL mice by modulating copper-catalyzed dicarbonyl stress
19. Modeling KLB deficiency by genome editing in hepatocytes: from oxidative stress and inflammation towards enhanced proliferation
20. Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease
21. Oleuropein prevents liver damage in NAFL mice by modulating copper-catalyzed dicarbonyl stress
22. OC-01Oleuropein prevents copper-catalyzed dicarbonyl stress in NAFLD mice
23. OC-02Activation of Liver X Receptor-α in the gut protects against liver injury in nonalcoholic steatohepatitis (NASH)
24. OC-05The nexus between LncOb rs10487505 variant, leptin levels and non-alcoholic fatty liver disease in children and adolescents
25. OC-02Activation of Liver X Receptor-α in the gut protects against liver injury in nonalcoholic steatohepatitis (NASH)
26. Modeling KLB deficiency by genome editing in hepatocytes: from oxidative stress and inflammation towards enhanced proliferation
27. The PSRC1 rs599839 A>G variant disentangles the risk of coronary artery disease and hepatocellular carcinoma in Italian NAFLD patients
28. TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models
29. The role of variant rs17618244 of KLB gene in MAFLD-related fibrosis
30. Copper chelation as a new treatment strategy to counteract hepatocellular carcinoma
31. Angiopoietin-2 associated with NASH in paediatric NAFLD
32. Hepatitis C virus core protein enhances B lymphocyte proliferation
33. Hepatitis C virus (HCV): an RNA virus with a pro-oncogenic potential
34. The role of variant rs17618244 of KLB gene in MAFLD-related fibrosis
35. Copper chelation as a new treatment strategy to counteract hepatocellular carcinoma
36. OC-05The nexus between LncOb rs10487505 variant, leptin levels and non-alcoholic fatty liver disease in children and adolescents
37. OC-01Oleuropein prevents copper-catalyzed dicarbonyl stress in NAFLD mice
38. Inhibition of isoform D of phosphodiesterase type 4 reduces cell proliferation and survival in hepatocarcinoma cell lines
39. Selective LXR α intestinal activation reduces hepatic inflammation and fibrosis during the development of chronic liver injury
40. The PSRC1 rs599839 A>G variant disentangles the risk of coronary artery disease and hepatocellular carcinoma in Italian NAFLD patients
41. TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models
42. The anti-inflammatory effects of hydroxytyrosol and vitamin e on paediatric NAFLD
43. Angiopoietin-2 associated with NASH in paediatric NAFLD
44. AISF position paper on liver transplantation and pregnancy
45. Selective LXR α intestinal activation reduces hepatic inflammation and fibrosis during the development of chronic liver injury
46. Inhibition of isoform D of phosphodiesterase type 4 reduces cell proliferation and survival in hepatocarcinoma cell lines
47. Combined therapy with Sorafenib and FAK inhibitor TAE226 impairs hepatocellular carcinoma growth by interfering with epigenetic modifications and stemness markers
48. P018 The Nox2: the new marker of stress oxidative in non-alcoholic steatohepatitis in children
49. P024 The role of hepatic Farnesoid X receptor protein level in hepatic zonal metabolism
50. P.09.17 PNPLA3 RS738409 POLYMORPHISM PREDICTS THE DEVELOPMENT AND THE SEVERITY OF HEPATIC STEATOSIS, BUT NOT METABOLIC SYNDROME, IN PATIENTS WITH CELIAC DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.